Sign in
Taking peopleNo phase

Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome

Key facts

Who runs it
Center of New Medical Technologies
Where
Russia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
1 Apr 2026
Expected to end
1 Jul 2028
Type of study
Observational, 2 groups
Record updated
30 March 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Verified MS per NCEP-ATP III criteria
  • Ability to undergo all procedures (fasting blood draw, breath test, stool antigen, endoscopy/biopsy, anthropometry)

Who cannot take part

  • Current metabolic-influencing therapy
  • Planned surgery/long hospitalization
  • Gastric resection or upper GI reconstruction
  • Acute/chronic infection or autoimmune flare
  • Active malignancies
  • Severe liver/kidney failure
  • Type 1 diabetes
  • Interventional study participation in last 3 months
  • Pregnancy/lactation

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial is currently available in Russia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This retrospective cohort study evaluates the association between H. pylori persistence and insulin resistance severity (HOMA-IR) in 100 patients with metabolic syndrome at Novosibirsk's Center for New Medical Technologies (CNMT). Patients are divided into infected (n=50) and non-infected (n=50) groups, assessing metabolic parameters, gastro panel, and CRP. Primary endpoint: HOMA-IR differences; secondary: correlations with gastric inflammation and metabolic markers.

The 2 groups in the trial

  • group with persistence of H. pylori

    group with metabolic syndrome and persistence of H. pylori

  • group without persistence of H. pylori

    group without metabolic syndrome and persistence of H. pylori

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome Cohort Observational Study
Criteria questions
Built from NCT07501858, who can take part
Record updated
30 March 2026